EUVIMEDEUVIMED entdecken
Crossref

Testosterone reference ranges in women, adolescent girls, and children: the 2024 PCOS Challenge-CDC stakeholder meeting

Sasha Ottey, Fidelia Pokuah, Melanie G Cree, Katherine Sherif, Hubert W Vesper, Alicia N Lyle, Ricardo Azziz iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Sasha Ottey und 6 weiteren Autor:innen. Beteiligte Einrichtung: PCOS Challenge: The National Polycystic Ovary Syndrome Association, Atlanta, GA 30308, USA. Hauptthemen laut MEDLINE: Testosterone, Polycystic Ovary Syndrome. Die Arbeit nennt 74 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Testosterone measurement is fundamental to the management of many disorders in women, adolescent girls, and children, most notably androgen excess, including polycystic ovary syndrome (PCOS, aka polyendocrine metabolic ovarian syndrome [PMOS]) and congenital adrenal hyperplasia, and androgen deficiency disorders. Despite 2 decades of progress in testosterone assay standardization, pediatric and adult female reference intervals (RIs) remain highly variable across laboratories and assay systems, limiting diagnostic accuracy and clinical decision-making.

Objective

On August 26, 2024, PCOS Challenge: The National Polycystic Ovary Syndrome Association, in collaboration with the Centers for Disease Control and Prevention (CDC) Clinical Standardization Programs, convened a stakeholder meeting.

Results

Participants reviewed the historical trajectory of testosterone standardization, clinical need for sex- and age-specific RI, current RI limitations, technical challenges of measuring testosterone at female and pediatric concentrations, and a validated methodology for normalizing and combining data across existing cohorts using CDC reference measurements. Nine women's and adolescent health cohorts were identified as candidates for RI development, and an estradiol RI precedent was presented as proof of concept using the same data harmonization approach.

Conclusion

Recommendations across 7 domains were proposed: (1) assay standardization, (2) reference population characterization, (3) study design parameters, (4) data integration standards, (5) educational outreach, (6) global access, and (7) need for standardized RI for additional relevant biomarkers, including Anti-Müllerian Hormone and 11-oxygenated androgens. A 4-phase work plan was proposed for cohort identification, specimen re-analysis at the CDC laboratory, statistical analysis, and peer-reviewed publication of the resulting RI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteronePolycystic Ovary SyndromeHumansFemaleAdolescentReference ValuesChildCenters for Disease Control and Prevention, U.S.United StatesAdultYoung Adult

Stichwörter der Autor:innen

androgensclinical standardization programslaboratory standardizationpolycystic ovary syndromereference intervalstestosterone

Substanzen

Testosterone

Autor:innen und Institutionen

  • PCOS Challenge: The National Polycystic Ovary Syndrome Association, Atlanta, GA 30308, USA.
  • Clinical Standardization Programs, Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
  • Department of Pediatrics, University of Colorado Anschutz and Children's Hospital Colorado, Aurora, CO 80045, USA.
  • Department of Medicine, Jefferson Women's Primary Care, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Department of Obstetrics & Gynecology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35249, USA.
  • Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35249, USA.

ORCID-Profile: Ricardo Azziz

Zitieren

APA

Ottey, S., Pokuah, F., Cree, M. G., Sherif, K., Vesper, H. W., Lyle, A. N., & Azziz, R. (2026). Testosterone reference ranges in women, adolescent girls, and children: the 2024 PCOS Challenge-CDC stakeholder meeting. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag276

Vancouver

Ottey S, Pokuah F, Cree MG, Sherif K, Vesper HW, Lyle AN, et al. Testosterone reference ranges in women, adolescent girls, and children: the 2024 PCOS Challenge-CDC stakeholder meeting. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag276

BibTeX
@article{Ottey2026,
  author = {Ottey, Sasha and Pokuah, Fidelia and Cree, Melanie G and Sherif, Katherine and Vesper, Hubert W and Lyle, Alicia N and Azziz, Ricardo},
  title = {Testosterone reference ranges in women, adolescent girls, and children: the 2024 PCOS Challenge-CDC stakeholder meeting},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag276}
}
Kostenlos starten →